ISRCTN31751611已完成不适用
Budesonide as treatment for patients with irritable bowel syndrome
Academic Medical Centre (AMC) (The Netherlands)0 个研究点目标入组 32 人开始时间: 2005年8月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Fulfilling Rome II criteria of Irritable Bowel Syndrome (IBS)
- •2. 18 to 65 years of age
- •3. No other organic abnormalities explaining the complaints
排除标准
- •1. Severe comorbidity
- •2. Pregnancy/lactation
研究者
相似试验
暂停
不适用
Irritable Bowel Syndrome - Budesonide.NL-OMON2875832
尚未招募
不适用
Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID casesCTRI/2020/10/028581Dr Tushar Patel
招募中
3 期
Effectiveness of the Treatment With Budesonide Nebuliser among Patients with Acute AsthmaIRCT20170531034256N2Shahid Beheshti University of Medical Sciences70
已完成
3 期
Budesonide for Induction of Remission in Incomplete Microscopic ColitisIncomplete Microscopic ColitisNCT02142634Dr. Falk Pharma GmbH44
招募中
2 期
Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosisCrohn's diseaseJPRN-jRCT1051190043Takehara Tetsuo15